Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricky W Johnstone

Showing results (1-10 of 188) with videos related to

Pageof 19
Sort By:
Molecular Cell|November 7, 2002
Deamidation of Bcl-X(L): a new twist in a genotoxic murder mysteryRicky W Johnstone
Idrugs : the Investigational Drugs Journal|July 10, 2004
Suberanilohydroxamic Acid. Aton PharmaRicky W Johnstone
Nature Reviews. Drug Discovery|July 18, 2002
Histone-deacetylase inhibitors: novel drugs for the treatment of cancerRicky W Johnstone
Cold Spring Harbor Protocols|December 10, 2016
In the Midst of Life-Cell Death: What Is It, What Is It Good for, and How to Study ItJohn Silke, Ricky W Johnstone
Cold Spring Harbor Perspectives in Biology|December 5, 2012
Oncogenes in cell survival and cell deathJake Shortt, Ricky W Johnstone
Cancer Discovery|May 16, 2012
Regulating the TRAIL of destruction: how A20 protects glioblastomas from TRAIL-mediated deathInge Verbrugge, Ricky W Johnstone
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
Rational combinations using HDAC inhibitorsMichael Bots, Ricky W Johnstone
Cancer Cell|August 2, 2003
Histone deacetylase inhibitors in cancer therapy: is transcription the primary target?Ricky W Johnstone, Jonathan D Licht
The Journal of Clinical Investigation|January 3, 2014
New and emerging HDAC inhibitors for cancer treatmentAlison C West, Ricky W Johnstone
Nature Reviews. Drug Discovery|August 19, 2014
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disordersKatrina J Falkenberg, Ricky W Johnstone
Pageof 19

Showing results (1-10 of 188) with videos related to

Sort By:
Pageof 19
Molecular Cell|November 7, 2002
Deamidation of Bcl-X(L): a new twist in a genotoxic murder mysteryRicky W Johnstone
Idrugs : the Investigational Drugs Journal|July 10, 2004
Suberanilohydroxamic Acid. Aton PharmaRicky W Johnstone
Nature Reviews. Drug Discovery|July 18, 2002
Histone-deacetylase inhibitors: novel drugs for the treatment of cancerRicky W Johnstone
Cold Spring Harbor Protocols|December 10, 2016
In the Midst of Life-Cell Death: What Is It, What Is It Good for, and How to Study ItJohn Silke, Ricky W Johnstone
Cold Spring Harbor Perspectives in Biology|December 5, 2012
Oncogenes in cell survival and cell deathJake Shortt, Ricky W Johnstone
Cancer Discovery|May 16, 2012
Regulating the TRAIL of destruction: how A20 protects glioblastomas from TRAIL-mediated deathInge Verbrugge, Ricky W Johnstone
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
Rational combinations using HDAC inhibitorsMichael Bots, Ricky W Johnstone
Cancer Cell|August 2, 2003
Histone deacetylase inhibitors in cancer therapy: is transcription the primary target?Ricky W Johnstone, Jonathan D Licht
The Journal of Clinical Investigation|January 3, 2014
New and emerging HDAC inhibitors for cancer treatmentAlison C West, Ricky W Johnstone
Nature Reviews. Drug Discovery|August 19, 2014
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disordersKatrina J Falkenberg, Ricky W Johnstone
Pageof 19